MedPath
HSA Approval

VORICONAZOLE SANDOZ FILM COATED TABLET 200MG

SIN14859P

VORICONAZOLE SANDOZ FILM COATED TABLET 200MG

VORICONAZOLE SANDOZ FILM COATED TABLET 200MG

October 6, 2015

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J02ACO3

xj 02 aco 3

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Sandoz Private Limited

Active Ingredients

Voriconazole (Micronized)

200mg

Voriconazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VORICONAZOLE SANDOZ FILM COATED TABLET 200MG - HSA Approval | MedPath